#BEGIN_DRUGCARD DB04555

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
63-38-7

# ChEBI_ID:
17239

# Chemical_Formula:
C9H15N3O11P2

# Chemical_IUPAC_Name:
[({[(2S,3R,4R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphonic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Cytidine 5&#39;-(trihydrogen diphosphate). A cytosine nucleotide containing two phosphate groups esterified to the sugar moiety. Synonyms: CRPP; cytidine pyrophosphate. [PubChem]

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Cytidine-5'-Diphosphate

# HET_ID:
CDF

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C9H15N3O11P2/c10-5-1-2-12(9(15)11-5)8-7(14)6(13)4(22-8)3-21-25(19,20)23-24(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H2,10,11,15)(H2,16,17,18)/t4-,6-,7+,8+/m0/s1

# InChI_Key:
InChIKey=ZWIADYZPOWUWEW-ZAKLUEHWSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C00112

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4555

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
403.1764

# Molecular_Weight_Mono:
403.018181361

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1GX1

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1.4

# Predicted_LogS:
-1.6

# Predicted_Water_Solubility:
1.01e+01 g/l

# Primary_Accession_No:
DB04555

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46937009

# PubChem_Substance_ID:
46508856

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00868

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
NC1=NC(=O)N(C=C1)[C@@H]1O[C@@H](CO[P@](O)(=O)OP(O)(O)=O)[C@H](O)[C@H]1O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:27 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AB082126

# Drug_Target_1_GenBank_ID_Protein:
19911566

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
ispF

# Drug_Target_1_Gene_Sequence:
>459 bp
ATGCGCATCGGCTACGGCGAGGACAGCCACCGCCTGGAGGAGGGGAGGCCGCTTTACCTC
TGCGGCCTCCTCATTCCAAGCCCCGTGGGGGCCCTGGCCCACTCCGATGGGGACGCCGCC
CTCCACGCCCTCACCGACGCCCTCCTTTCCGCCTACGGCCTTGGGGACATCGGCCTCCTC
TTCCCCGACACCGATCCCCGCTGGCGGGGCGAGCGGAGCGAGGTGTTTCTCCGGGAGGCC
CTCCGCCTCGTGGAAGCGCGGGGGGCGAAGCTGCTTCAGGCGAGCCTCGTCCTCACCCTG
GACCGGCCCAAGCTCGGCCCCCACCGCAAGGCCTTGGTGGACAGCCTATCCCGCCTCCTC
CGCCTTCCCCAGGACCGCATTGGCCTCACCTTCAAGACCTCGGAGGGCCTGGCGCCTTCC
CACGTCCAGGCCCGGGCGGTGGTGCTTCTGGATGGTTGA

# Drug_Target_1_General_Function:
Lipid transport and metabolism

# Drug_Target_1_General_References:
Not Available

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2937

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
16520

# Drug_Target_1_Name:
2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase

# Drug_Target_1_Number_of_Residues:
152

# Drug_Target_1_PDB_ID:
1IV1

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF02542	YgbB

# Drug_Target_1_Protein_Sequence:
>2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase
MRIGYGEDSHRLEEGRPLYLCGLLIPSPVGALAHSDGDAALHALTDALLSAYGLGDIGLL
FPDTDPRWRGERSEVFLREALRLVEARGAKLLQASLVLTLDRPKLGPHRKALVDSLSRLL
RLPQDRIGLTFKTSEGLAPSHVQARAVVLLDG

# Drug_Target_1_Reaction:
2-phospho-4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol = 2-C-methyl-D-erythritol 2,4-cyclodiphosphate + CMP

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Converts 4-diphosphocytidyl-2-C-methyl-D-erythritol 2- phosphate into 2-C-methyl-D-erythritol 2,4-cyclodiphosphate (MECDP) and CMP

# Drug_Target_1_SwissProt_ID:
Q8RQP5

# Drug_Target_1_SwissProt_Name:
ISPF_THET8

# Drug_Target_1_Synonyms:
EC 4.6.1.12
MECDP-synthase
MECPS

# Drug_Target_1_Theoretical_pI:
7.73

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Cytoplasm

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
U60146

# Drug_Target_2_GenBank_ID_Protein:
1549341

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
neuA

# Drug_Target_2_Gene_Sequence:
>687 bp
ATGGAAAAACAAAATATTGCGGTTATACTTGCGCGCCAAAACTCCAAAGGATTGCCATTA
AAAAATCTCCGGAAAATGAATGGCATATCATTACTTGGTCATACAATTAATGCTGCTATA
TCATCAAAGTGTTTTGACCGCATAATTGTTTCGACTGATGGCGGGTTAATTGCAGAAGAA
GCTAAAAATTTCGGTGTCGAAGTCGTCCTACGCCCTGCAGAGCTGGCCTCCGATACAGCC
AGCTCTATTTCAGGTGTAATACATGCTTTAGAAACAATTGGCAGTAATTCCGGCACAGTA
ACCCTATTACAACCAACCAGTCCATTACGCACAGGGGCTCATATTCGTGAAGCTTTTTCT
CTATTTGATGAGAAAATAAAAGGATCCGTTGTCTCTGCATGCCCAATGGAGCATCATCCA
CTAAAAACCCTGCTTCAAATCAATAATGGCGAATATGCCCCCATGCGCCATCTAAGCGAT
TTGGAGCAGCCTCGCCAACAATTACCTCAGGCATTTAGGCCTAATGGTGCAATTTACATT
AATGATACTGCTTCACTAATTGCAAATAATTGTTTTTTTATCGCTCCAACCAAACTTTAT
ATTATGTCTCATCAAGACTCTATCGATATTGATACTGAGCTTGATTTACAACAGGCAGAA
AACATTCTTAATCACAAGGAAAGCTAA

# Drug_Target_2_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_2_General_References:
Not Available

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
2944

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
24893

# Drug_Target_2_Name:
N-acylneuraminate cytidylyltransferase

# Drug_Target_2_Number_of_Residues:
228

# Drug_Target_2_PDB_ID:
1EYR

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF02348	CTP_transf_3

# Drug_Target_2_Protein_Sequence:
>N-acylneuraminate cytidylyltransferase
MEKQNIAVILARQNSKGLPLKNLRKMNGISLLGHTINAAISSKCFDRIIVSTDGGLIAEE
AKNFGVEVVLRPAELASDTASSISGVIHALETIGSNSGTVTLLQPTSPLRTGAHIREAFS
LFDEKIKGSVVSACPMEHHPLKTLLQINNGEYAPMRHLSDLEQPRQQLPQAFRPNGAIYI
NDTASLIANNCFFIAPTKLYIMSHQDSIDIDTELDLQQAENILNHKES

# Drug_Target_2_Reaction:
CTP + N-acylneuraminate = diphosphate + CMP-N-acylneuraminate

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
CTP + N-acylneuraminate = diphosphate + CMP-N- acylneuraminate

# Drug_Target_2_SwissProt_ID:
P0A0Z8

# Drug_Target_2_SwissProt_Name:
NEUA_NEIME

# Drug_Target_2_Synonyms:
CMP-N- acetylneuraminic acid synthetase
CMP-NeuNAc synthetase
CMP-sialic acid synthetase
EC 2.7.7.43

# Drug_Target_2_Theoretical_pI:
6.51

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Cytoplasm

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
X00785

# Drug_Target_3_GenBank_ID_Protein:
42839

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
cmk

# Drug_Target_3_Gene_Sequence:
>684 bp
ATGACGGCAATTGCCCCGGTTATTACCATTGATGGCCCAAGCGGTGCAGGGAAAGGCACC
TTGTGTAAGGCTATGGCGGAAGCGTTGCAATGGCATCTGCTGGACTCGGGTGCAATTTAT
CGCGTACTGGCATTGGCGGCATTACATCACCATGTTGATGTTGCGTCGGAAGATGCGCTG
GTACCGCTGGCATCCCATCTGGATGTACGTTTTGTGTCGACCAATGGCAATCTGGAAGTG
ATCCTCGAAGGGGAAGATGTCAGCGGCGAAATTCGTACTCAGGAAGTGGCGAATGCAGCT
TCACAAGTCGCGGCATTCCCACGCGTTCGTGAAGCATTATTGCGTCGCCAACGCGCGTTT
CGCGAATTACCAGGTCTGATTGCCGATGGCCGCGACATGGGAACGGTGGTATTCCCTGAT
GCACCAGTGAAAATTTTCCTTGACGCCTCCTCGGAAGAACGTGCGCATCGCCGCATGCTA
CAGTTGCAGGTGAAGGGCTTTAGTGTTAACTTTGAGCGCCTTTTGGCCGAGATCAAAGAA
CGCGACGACCGCGATCGTAACCGAGCGGTAGCGCCACTGGTTCCGGCAGCCGATGCTTTA
GTGTTGGATTCCACCACCTTAAGCATTGAGCAAGTGATTGAAAAAGCGCTACAATACGCG
CGCCAGAAATTGGCTCTCGCATAA

# Drug_Target_3_General_Function:
Nucleotide transport and metabolism

# Drug_Target_3_General_References:
6281725	Schnier J, Isono K: The DNA sequence of the gene rpsA of Escherichia coli coding for ribosomal protein S1. Nucleic Acids Res. 1982 Mar 25;10(6):1857-65.
6384724	Pedersen S, Skouv J, Kajitani M, Ishihama A: Transcriptional organization of the rpsA operon of Escherichia coli. Mol Gen Genet. 1984;196(1):135-40.
7836281	Fricke J, Neuhard J, Kelln RA, Pedersen S: The cmk gene encoding cytidine monophosphate kinase is located in the rpsA operon and is required for normal replication rate in Escherichia coli. J Bacteriol. 1995 Feb;177(3):517-23.
8190075	Yamanaka K, Ogura T, Koonin EV, Niki H, Hiraga S: Multicopy suppressors, mssA and mssB, of an smbA mutation of Escherichia coli. Mol Gen Genet. 1994 Apr;243(1):9-16.
8905232	Oshima T, Aiba H, Baba T, Fujita K, Hayashi K, Honjo A, Ikemoto K, Inada T, Itoh T, Kajihara M, Kanai K, Kashimoto K, Kimura S, Kitagawa M, Makino K, Masuda S, Miki T, Mizobuchi K, Mori H, Motomura K, Nakamura Y, Nashimoto H, Nishio Y, Saito N, Horiuchi T, et al.: A 718-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 12.7-28.0 min region on the linkage map. DNA Res. 1996 Jun 30;3(3):137-55.
9126287	Schultz CP, Ylisastigui-Pons L, Serina L, Sakamoto H, Mantsch HH, Neuhard J, Barzu O, Gilles AM: Structural and catalytic properties of CMP kinase from Bacillus subtilis: a comparative analysis with the homologous enzyme from Escherichia coli. Arch Biochem Biophys. 1997 Apr 1;340(1):144-53.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9862805	Briozzo P, Golinelli-Pimpaneau B, Gilles AM, Gaucher JF, Burlacu-Miron S, Sakamoto H, Janin J, Barzu O: Structures of escherichia coli CMP kinase alone and in complex with CDP: a new fold of the nucleoside monophosphate binding domain and insights into cytosine nucleotide specificity. Structure. 1998 Dec 15;6(12):1517-27.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
2909

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
24747

# Drug_Target_3_Name:
Cytidylate kinase

# Drug_Target_3_Number_of_Residues:
227

# Drug_Target_3_PDB_ID:
1KDT

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF02224	Cytidylate_kin

# Drug_Target_3_Protein_Sequence:
>Cytidylate kinase
MTAIAPVITIDGPSGAGKGTLCKAMAEALQWHLLDSGAIYRVLALAALHHHVDVASEDAL
VPLASHLDVRFVSTNGNLEVILEGEDVSGEIRTQEVANAASQVAAFPRVREALLRRQRAF
RELPGLIADGRDMGTVVFPDAPVKIFLDASSEERAHRRMLQLQEKGFSVNFERLLAEIKE
RDDRDRNRAVAPLVPAADALVLDSTTLSIEQVIEKALQYARQKLALA

# Drug_Target_3_Reaction:
ATP + (d)CMP = ADP + (d)CDP

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
ATP, dATP, and GTP are equally effective as phosphate donors. CMP and dCMP are the best phosphate acceptors

# Drug_Target_3_SwissProt_ID:
P0A6I0

# Drug_Target_3_SwissProt_Name:
KCY_ECOLI

# Drug_Target_3_Synonyms:
CK
CMP kinase
Cytidine monophosphate kinase
EC 2.7.4.14
Protein mssA
p25

# Drug_Target_3_Theoretical_pI:
5.65

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Not Available

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
M29682

# Drug_Target_4_GenBank_ID_Protein:
154340

# Drug_Target_4_GeneCard_ID:
Not Available

# Drug_Target_4_Gene_Name:
rfbE

# Drug_Target_4_Gene_Sequence:
>1017 bp
ATGAAGCTTTTAATTACCGGTGGATGTGGCTTCCTTGGGAGTAATCTTGCCTCCTTTGCT
TTAAGTCAAGGGATTGATTTAATTGTATTCGATAATCTATCACGTAAAGGTGCAACAGAT
AATTTACATTGGTTATCCTCCTTAGGAAACTTTGAGTTTGTACATGGTGATATTCGCAAC
AAAAATGATGTTACAAGATTAATAACTAAGTATATGCCTGATAGCTGTTTTCATCTTGCA
GGTCAAGTGGCAATGACTACATCTATTGACAATCCTTGTATGGATTTTGAAATTAATGTA
GGTGGAACTTTAAATTTACTTGAGGCAGTACGGCAGTATAATTCAAATTGTAATATAATT
TATTCATCAACAAATAAAGTATACGGCGATCTTGAGCAATATAAATACAATGAAACAGAA
ACTAGATACACTTGTGTAGATAAGCCTAATGGATATGATGAGAGCACACAATTAGATTTC
CACTCACCATATGGTTGTTCAAAAGGTGCTGCAGACCAATACATGCTTGATTATGCAAGG
ATTTTTGGTTTGAATACAGTGGTGTTCAGGCATTCATCAATGTATGGTGGGAGACAGTTT
GCTACTTATGATCAAGGCTGGGTAGGTTGGTTTTGTCAAAAAGCGGTTGAAATTAAAAAT
GGTATTAATAAACCCTTCACTATTTCTGGTAATGGTAAGCAAGTTAGGGATGTTTTGCAT
GCTGAAGATATGATTTCGTTATATTTCACTGCCTTGGCAAATGTATCAAAAATTAGGGGG
AACGCTTTTAATATTGGTGGTACCATTGTCAACAGCCTATCATTACTTGAATTATTCAAA
TTGCTTGAAGATTATTGCAACATAGATATGAGGTTCACTAATTTACCTGTAAGGGAAAGT
GATCAGCGTGTTTTTGTTGCAGATATTAAAAAAATCACTAATGCAATTGACTGGAGCCCG
AAAGTCTCGGCAAAAGATGGTGTCCAGAAAATGTATGATTGGACTAGTTCTATATGA

# Drug_Target_4_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_4_General_References:
11677608	Parkhill J, Dougan G, James KD, Thomson NR, Pickard D, Wain J, Churcher C, Mungall KL, Bentley SD, Holden MT, Sebaihia M, Baker S, Basham D, Brooks K, Chillingworth T, Connerton P, Cronin A, Davis P, Davies RM, Dowd L, White N, Farrar J, Feltwell T, Hamlin N, Haque A, Hien TT, Holroyd S, Jagels K, Krogh A, Larsen TS, Leather S, Moule S, O'Gaora P, Parry C, Quail M, Rutherford K, Simmonds M, Skelton J, Stevens K, Whitehead S, Barrell BG: Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18. Nature. 2001 Oct 25;413(6858):848-52.
12642575	Koropatkin NM, Liu HW, Holden HM: High resolution x-ray structure of tyvelose epimerase from Salmonella typhi. J Biol Chem. 2003 Jun 6;278(23):20874-81. Epub 2003 Mar 17.
12644504	Deng W, Liou SR, Plunkett G 3rd, Mayhew GF, Rose DJ, Burland V, Kodoyianni V, Schwartz DC, Blattner FR: Comparative genomics of Salmonella enterica serovar Typhi strains Ty2 and CT18. J Bacteriol. 2003 Apr;185(7):2330-7.
2793833	Verma N, Reeves P: Identification and sequence of rfbS and rfbE, which determine antigenic specificity of group A and group D salmonellae. J Bacteriol. 1989 Oct;171(10):5694-701.

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
2967

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
37958

# Drug_Target_4_Name:
CDP-paratose 2-epimerase

# Drug_Target_4_Number_of_Residues:
338

# Drug_Target_4_PDB_ID:
1ORR

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF01370	Epimerase

# Drug_Target_4_Protein_Sequence:
>CDP-paratose 2-epimerase
MKLLITGGCGFLGSNLASFALSQGIDLIVFDNLSRKGATDNLHWLSSLGNFEFVHGDIRN
KNDVTRLITKYMPDSCFHLAGQVAMTTSIDNPCMDFEINVGGTLNLLEAVRQYNSNCNII
YSSTNKVYGDLEQYKYNETETRYTCVDKPNGYDESTQLDFHSPYGCSKGAADQYMLDYAR
IFGLNTVVFRHSSMYGGRQFATYDQGWVGWFCQKAVEIKNGINKPFTISGNGKQVRDVLH
AEDMISLYFTALANVSKIRGNAFNIGGTIVNSLSLLELFKLLEDYCNIDMRFTNLPVRES
DQRVFVADIKKITNAIDWSPKVSAKDGVQKMYDWTSSI

# Drug_Target_4_Reaction:
CDP-3,6-dideoxy-D-glucose = CDP-3,6-dideoxy-D-mannose

# Drug_Target_4_Signals:
None

# Drug_Target_4_Specific_Function:
Catalyzes the isomeration of CDP-paratose to CDP- tyvelose

# Drug_Target_4_SwissProt_ID:
P14169

# Drug_Target_4_SwissProt_Name:
RFBE_SALTI

# Drug_Target_4_Synonyms:
CDP-tyvelose 2-epimerase
EC 5.1.3.10

# Drug_Target_4_Theoretical_pI:
6.25

# Drug_Target_4_Transmembrane_Regions:
None

# Drug_Target_5_Cellular_Location:
Not Available

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_5_Essentiality:
Non-Essential

# Drug_Target_5_GenAtlas_ID:
Not Available

# Drug_Target_5_GenBank_ID_Gene:
AE005674

# Drug_Target_5_GenBank_ID_Protein:
24053164

# Drug_Target_5_GeneCard_ID:
Not Available

# Drug_Target_5_Gene_Name:
ispF

# Drug_Target_5_Gene_Sequence:
>480 bp
TCATTTTGTTGCCTTAATGAGTAGCGCCACCGCTTCACAGGCAATCCCTTCCCCACGTCC
GGTAAATCCAAGTTTTTCCGTAGTAGTGGCTTTCACGTTAACATCATCCATATGGCAGCC
GAGATCTTCGGCAATAAACACGCGCATTTGTGGAATGTGCGGCAACATCTTCGGTGCCTG
AGCGATGATAGTGACATCGACGTTGCCAAGGGTATAACCCTTCGCCTGAATACGACGCCA
GGCTTCGCGTAGCAGCTCGCGGCTGTCGGCACCTTTAAATGCCGGATCGGTATCCGGGAA
CAGTTTGCCGATATCCCCCAGCGCCGCCGCGCCAAGCAATGCATCGGTCAACGCATGAAG
CGCCACGTCGCCATCAGAATGCGCCAGCAATCCTTTTTCGTAAGGAATGCGTACGCCACC
AATGATAATTGGGCCTTCACCGCCAAAGGCGTGTACGTCAAAACCGTGTCCAATTCGCAT

# Drug_Target_5_General_Function:
Lipid transport and metabolism

# Drug_Target_5_General_References:
12384590	Jin Q, Yuan Z, Xu J, Wang Y, Shen Y, Lu W, Wang J, Liu H, Yang J, Yang F, Zhang X, Zhang J, Yang G, Wu H, Qu D, Dong J, Sun L, Xue Y, Zhao A, Gao Y, Zhu J, Kan B, Ding K, Chen S, Cheng H, Yao Z, He B, Chen R, Ma D, Qiang B, Wen Y, Hou Y, Yu J: Genome sequence of Shigella flexneri 2a: insights into pathogenicity through comparison with genomes of Escherichia coli K12 and O157. Nucleic Acids Res. 2002 Oct 15;30(20):4432-41.
12704152	Wei J, Goldberg MB, Burland V, Venkatesan MM, Deng W, Fournier G, Mayhew GF, Plunkett G 3rd, Rose DJ, Darling A, Mau B, Perna NT, Payne SM, Runyen-Janecky LJ, Zhou S, Schwartz DC, Blattner FR: Complete genome sequence and comparative genomics of Shigella flexneri serotype 2a strain 2457T. Infect Immun. 2003 May;71(5):2775-86.

# Drug_Target_5_HGNC_ID:
Not Available

# Drug_Target_5_HPRD_ID:
Not Available

# Drug_Target_5_ID:
2383

# Drug_Target_5_Locus:
Not Available

# Drug_Target_5_Molecular_Weight:
16898

# Drug_Target_5_Name:
2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase

# Drug_Target_5_Number_of_Residues:
159

# Drug_Target_5_PDB_ID:
1U43

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
PF02542	YgbB

# Drug_Target_5_Protein_Sequence:
>2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase
MRIGHGFDVHAFGGEGPIIIGGVRIPYEKGLLAHSDGDVALHALTDALLGAAALGDIGKL
FPDTDPAFKGADSRELLREAWRRIQAKGYTLGNVDVTIIAQAPKMLPHIPQMRVFIAEDL
GCHMDDVNVKATTTEKLGFTGRGEGIACEAVALLIKATK

# Drug_Target_5_Reaction:
2-phospho-4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol = 2-C-methyl-D-erythritol 2,4-cyclodiphosphate + CMP

# Drug_Target_5_Signals:
None

# Drug_Target_5_Specific_Function:
Converts 4-diphosphocytidyl-2-C-methyl-D-erythritol 2- phosphate into 2-C-methyl-D-erythritol 2,4-cyclodiphosphate (MECDP) and CMP

# Drug_Target_5_SwissProt_ID:
P62619

# Drug_Target_5_SwissProt_Name:
ISPF_SHIFL

# Drug_Target_5_Synonyms:
EC 4.6.1.12
MECDP-synthase
MECPS

# Drug_Target_5_Theoretical_pI:
6.51

# Drug_Target_5_Transmembrane_Regions:
None

# Drug_Target_6_Cellular_Location:
Cytoplasm (Potential)

# Drug_Target_6_Chromosome_Location:
Not Available

# Drug_Target_6_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_6_Essentiality:
Non-Essential

# Drug_Target_6_GenAtlas_ID:
Not Available

# Drug_Target_6_GenBank_ID_Gene:
X74567

# Drug_Target_6_GenBank_ID_Protein:
397407

# Drug_Target_6_GeneCard_ID:
Not Available

# Drug_Target_6_Gene_Name:
kpsU

# Drug_Target_6_Gene_Sequence:
>741 bp
ATGAGCAAAGCAGTTATTGTCATTCCGGCTCGCTATGGCTCCTCGCGCCTGCCGGGTAAG
CCACTGCTCGATATTGTTGGTAAACCGATGATCCAGCATGTTTACGAGCGTGCGTTACAG
GTGGCGGGCGTTGCGGAAGTTTGGGTGGCAACAGACGATCCGCGTGTTGAACAGGCCGTA
CAGGCGTTTGGCGGGAAAGCCATCATGACGCGCAACGATCATGAATCCGGCACCGATCGG
CTGGTCGAGGTGATGCATAAAGTCGAGGCAGATATCTACATTAACCTGCAGGGCGACGAA
CCAATGATTCGCCCGCGGGATGTAGAAACGCTGCTACAAGGAATGCGTGACGATCCCGCG
TTGCCGGTGGCAACGCTATGCCACGCGATTTCTGCCGCAGAAGCGGCTGAGCCAAGCACG
GTAAAAGTGGTTGTGAATACCCGCCAGGATGCGCTTTATTTCAGCCGCTCACCGATTCCG
TATCCGCGTAATGCTGAAAAAGCGCGCTACCTGAAACACGTCGGTATTTACGCTTATCGT
CGCGATGTGCTGCAAAACTACAGCCAGTTACCGGAGTCCATGCCGGAGCAGGCGGAATCA
CTGGAGCAGCTAAGGTTGATGAACGCGGGGATCAACATCCGCACATTTGAGGTTGCCGCA
ACCGGTCCGGGCGTCGACACCCCAGCATGCCTGGAAAAAGTGCGCGCCCTGATGGCACAG
GAACTGGCTGAAAACGCATGA

# Drug_Target_6_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_6_General_References:
7875563	Rosenow C, Roberts IS, Jann K: Isolation from recombinant Escherichia coli and characterization of CMP-Kdo synthetase, involved in the expression of the capsular K5 polysaccharide (K-CKS). FEMS Microbiol Lett. 1995 Jan 15;125(2-3):159-64.
8397187	Pazzani C, Rosenow C, Boulnois GJ, Bronner D, Jann K, Roberts IS: Molecular analysis of region 1 of the Escherichia coli K5 antigen gene cluster: a region encoding proteins involved in cell surface expression of capsular polysaccharide. J Bacteriol. 1993 Sep;175(18):5978-83.
8706906	Jelakovic S, Jann K, Schulz GE: The three-dimensional structure of capsule-specific CMP: 2-keto-3-deoxy-manno-octonic acid synthetase from Escherichia coli. FEBS Lett. 1996 Aug 5;391(1-2):157-61.

# Drug_Target_6_HGNC_ID:
Not Available

# Drug_Target_6_HPRD_ID:
Not Available

# Drug_Target_6_ID:
2765

# Drug_Target_6_Locus:
Not Available

# Drug_Target_6_Molecular_Weight:
27159

# Drug_Target_6_Name:
3-deoxy-manno-octulosonate cytidylyltransferase

# Drug_Target_6_Number_of_Residues:
246

# Drug_Target_6_PDB_ID:
1GQC

# Drug_Target_6_Pathway:
Not Available

# Drug_Target_6_Pfam_Domain_Function:
PF02348	CTP_transf_3

# Drug_Target_6_Protein_Sequence:
>3-deoxy-manno-octulosonate cytidylyltransferase
MSKAVIVIPARYGSSRLPGKPLLDIVGKPMIQHVYERALQVAGVAEVWVATDDPRVEQAV
QAFGGKAIMTRNDHESGTDRLVEVMHKVEADIYINLQGDEPMIRPRDVETLLQGMRDDPA
LPVATLCHAISAAEAAEPSTVKVVVNTRQDALYFSRSPIPYPRNAEKARYLKHVGIYAYR
RDVLQNYSQLPESMPEQAESLEQLRLMNAGINIRTFEVAATGPGVDTPACLEKVRALMAQ
ELAENA

# Drug_Target_6_Reaction:
CTP + 3-deoxy-D-manno-octulosonate = diphosphate + CMP-3-deoxy-D-manno-octulosonate

# Drug_Target_6_Signals:
None

# Drug_Target_6_Specific_Function:
Activates KDO (a required 8-carbon sugar) for incorporation into bacterial lipopolysaccharide in Gram-negative bacteria

# Drug_Target_6_SwissProt_ID:
P42216

# Drug_Target_6_SwissProt_Name:
KPSU5_ECOLX

# Drug_Target_6_Synonyms:
CKS
CMP-2-keto-3-deoxyoctulosonic acid synthetase
CMP-KDO synthetase
EC 2.7.7.38

# Drug_Target_6_Theoretical_pI:
5.70

# Drug_Target_6_Transmembrane_Regions:
None

#END_DRUGCARD DB04555
